CCME GLOBAL LIMITED
Latest filings
- Allotment of 15.08 crore shares via preferential issues · Fund Raising
- Committee approves 15.08 crore preferential shares and two acquisitions · Fund Raising
- RTA compliance certificate for quarter ending September 2026 · Compliance
Snapshot
What the business is, and whether it's a good one at a fair price.
A Pharmaceuticals & Biotechnology company listed on BSE, reporting revenue of ₹0 Cr over the trailing twelve months.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals & Biotechnology peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from CCME GLOBAL LIMITED's filed financials and exchange disclosures
What does CCME GLOBAL LIMITED do?
CCME GLOBAL LIMITED is a Pharmaceuticals & Biotechnology company listed on BSE.
Is CCME GLOBAL LIMITED profitable?
No. Over the trailing twelve months CCME GLOBAL LIMITED reported a net loss of ₹0.86 Cr with no revenue reported.
Does CCME GLOBAL LIMITED pay a dividend?
Not in the latest reported year — CCME GLOBAL LIMITED's dividend payout for FY26 was nil.
Is CCME GLOBAL LIMITED debt-free?
Yes. It reported no borrowings on its 31 Mar 2026 balance sheet, and ₹0.00 Cr of cash.
Is CCME GLOBAL LIMITED expensive compared with its peers?
On trailing P/E, CCME GLOBAL LIMITED ranks 143 of 164 in Pharmaceuticals & Biotechnology — cheaper than 13% of them, against an industry median of 30.8×. This is a position, not a valuation judgement.
How much does the CCME GLOBAL LIMITED share price move in a day?
On a typical session CCME GLOBAL LIMITED moves 4.96% — that is the median absolute close-to-close move across its last 239 trading days. MarketPing measures each filing's price reaction against it.
Where can I track CCME GLOBAL LIMITED's announcements?
Every NSE and BSE filing by CCME GLOBAL LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.